Gendell Jeffrey L Avadel Pharmaceuticals PLC Transaction History

Gendell Jeffrey L

$2.57 Billion
Q1 2024

A detailed history of Gendell Jeffrey L transactions in Avadel Pharmaceuticals PLC stock. As of the latest transaction made, Gendell Jeffrey L holds 5,708,118 shares of AVDL stock, worth $80.3 Million. This represents 3.76% of its overall portfolio holdings.

Number of Shares

5,708,118

Previous 5,615,350 1.65%

Holding current value

$80.3 Million

Previous $79.3 Million 21.59%

% of portfolio

3.76%

Previous 4.35%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$12.55 - $17.22 $1.16 Million - $1.6 Million	92,768 Added 1.65%	5,708,118 $96.4 Million
Q3 2023 Nov 13, 2023	BUY	$10.3 - $15.99 $2.26 Million - $3.51 Million	219,290 Added 4.06%	5,615,350 $57.8 Million
Q2 2023 Aug 11, 2023	BUY	$8.48 - $16.48 $798,358 - $1.55 Million	94,146 Added 1.78%	5,396,060 $88.9 Million
Q1 2023 May 12, 2023	BUY	$6.41 - $9.95 $1.16 Million - $1.8 Million	181,309 Added 3.54%	5,301,914 $48.6 Million
Q4 2022 Feb 13, 2023	BUY	$5.73 - $10.0 $1.92 Million - $3.34 Million	334,278 Added 6.98%	5,120,605 $36.7 Million

Q3 2022 Nov 10, 2022	BUY	$2.57 - $7.31 $1.36 Million - $3.86 Million	527,631 Added 12.39%	4,786,327 $24 Million
Q2 2022 Aug 12, 2022	BUY	$1.07 - $6.95 $1.52 Million - $9.88 Million	1,421,265 Added 50.09%	4,258,696 $10.4 Million
Q1 2022 May 13, 2022	BUY	$5.46 - $8.29 $2.14 Million - $3.24 Million	391,132 Added 15.99%	2,837,431 $19.4 Million
Q4 2021 Feb 11, 2022	BUY	$7.34 - $11.18 $2.84 Million - $4.33 Million	387,529 Added 18.82%	2,446,299 $19.8 Million
Q3 2021 Nov 12, 2021	BUY	$6.49 - $9.91 $147,037 - $224,520	22,656 Added 1.11%	2,058,770 $20.2 Million
Q2 2021 Aug 13, 2021	BUY	$6.73 - $9.05 $688,324 - $925,606	102,277 Added 5.29%	2,036,114 $13.7 Million
Q1 2021 May 14, 2021	BUY	$6.61 - $10.07 $1.67 Million - $2.54 Million	252,446 Added 15.01%	1,933,837 $17.5 Million
Q4 2020 Feb 12, 2021	BUY	$5.03 - $7.95 $2.85 Million - $4.5 Million	566,180 Added 50.77%	1,681,391 $11.2 Million
Q3 2020 Nov 16, 2020	BUY	$5.02 - $8.98 $368,332 - $658,889	73,373 Added 7.04%	1,115,211 $5.62 Million
Q2 2020 Aug 13, 2020	BUY	$7.25 - $11.75 $3.54 Million - $5.74 Million	488,322 Added 88.22%	1,041,838 $8.42 Million
Q1 2020 May 15, 2020	SELL	$4.06 - $10.64 $2.41 Million - $6.31 Million	-593,248 Reduced 51.73%	553,516 $4.4 Million
Q4 2019 Feb 13, 2020	BUY	$3.34 - $7.7 $2.6 Million - $5.98 Million	777,038 Added 210.17%	1,146,764 $8.66 Million
Q3 2019 Nov 14, 2019	BUY	$1.92 - $4.47 $709,873 - $1.65 Million	369,726 New	369,726 $1.54 Million

Others Institutions Holding AVDL

# of Institutions

133

Shares Held

68.4M

Call Options Held

1.01M

Put Options Held

2.03M

View Full List

About AVADEL PHARMACEUTICALS PLC

Ticker AVDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,581,300
Market Cap $852M
Description
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...

More about AVDL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gendell Jeffrey L, based on Form 13F filings with the SEC.

News

Stay updated on Gendell Jeffrey L with notifications on news.

Account

Gendell Jeffrey L Avadel Pharmaceuticals PLC Transaction History